Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(30 sites)
United States
University Of Alabama, Birmingham, Alabama Childrens National Hospital, Washington D.C., District of Columbia Augusta University Georgia, Augusta, Georgia East Carolina University, Greenville, North Carolina East Carolina University, Greenville, North Carolina Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania Cook Childrens Medical Center, Fort Worth, Texas Belgium
Novartis Investigative Site, Brussels Novartis Investigative Site, Laken Novartis Investigative Site, Liège Brazil
Novartis Investigative Site, Salvador, Estado de Bahia Novartis Investigative Site, Ribeirão Preto, São Paulo Novartis Investigative Site, São Paulo, São Paulo Colombia
Novartis Investigative Site, Valledupar, Cesar Department Novartis Investigative Site, Cali, Valle del Cauca Department Novartis Investigative Site, Montería France
Novartis Investigative Site, Créteil Novartis Investigative Site, Paris Novartis Investigative Site, Paris Germany
Novartis Investigative Site, Heidelberg Italy
Novartis Investigative Site, Padova, PD Novartis Investigative Site, Orbassano, TO Lebanon
Novartis Investigative Site, Beirut Novartis Investigative Site, Tripoli Oman
Novartis Investigative Site, Khoudh Spain
Novartis Investigative Site, Barcelona Novartis Investigative Site, Madrid Turkey (Türkiye)
Novartis Investigative Site, Hatay, Antakya Novartis Investigative Site, Adana, Saricam Novartis Investigative Site, Adana, Yuregir